Longevity in the global market
Development of the longevity and anti-aging therapy market, key opportunities and analysis of leading players until 2028
Trends Market Research, Global Longevity And Anti Senescence Therapy Market
Translation: LEO, BBC24
The global market of drugs for the treatment of longevity and aging should grow from $329.8 million in 2018 to $644.4 million by 2023 with an average annual growth rate (CAGR) of 14.3% during 2018-2023.
Click here to get a sample of the premium report.
The scope of this report is extensive and covers various treatments that are currently being tested in the global market for longevity therapy and aging therapy. The market assessment was carried out taking into account revenue generation in the projected 2018-2023 years after the expected appearance of products on the market by 2023. The global market for longevity and anti-aging therapy has been segmented into the following therapies: senolytic drug therapy, gene therapy, immunotherapy and other therapies, including stem cell therapy, etc.
Revenue forecasts from 2028 to 2023 are provided for each therapy and application with calculated values based on expected revenues in the first year of launch.
Click here to make a purchase request or customize the report.
The report also includes a discussion of the main players conducting research, or potential players in each regional market of longevity and anti-aging therapy. In addition, it explains the main driving forces and regional dynamics of the global longevity and anti-aging therapy market, as well as current trends in the industry.
The report concludes with a special focus on the supplier environment and includes detailed profiles of key suppliers and potential participants in the global longevity and anti-aging therapy market.
The report includes:
– 71 data tables and 40 additional tables
– Overview of the global market of longevity and anti-aging therapy
– Analysis of global market trends with data for 2017 and 2018 and forecasts of cumulative annual growth rates (CAGR) until 2023.
– Country data and analysis for the USA, Canada, Japan, China, India, Great Britain, France, Germany, Spain, Australia, the Middle East and Africa.
– A detailed description of various methods of aging treatment, such as senolytic drug therapy, gene therapy, immunotherapy and other stem cell therapies, and their effect on slowing aging or reversing the aging process.
– Coverage of various therapeutic drugs, devices and technologies, as well as information on compounds used to develop anti-aging therapeutics.
– A look at clinical trials and the expected launch of anti-aging products
– Detailed profiles of leading companies and potential participants in the global longevity and anti-aging therapy market, including AgeX Therapeutics, CohBar Inc., PowerVision Inc., T.A. Sciences and Unity of Biotechnology
The global longevity and anti-aging therapy market is engaged in the introduction of various treatment methods and treatment options used to increase human life expectancy.
"Human longevity" is commonly used to describe a person's lifespan and is sometimes used as a synonym for "longevity" in demography.
"Anti–aging" is a process in which cells cease to divide irreversibly and go into a stage of permanent growth arrest, which excludes cell death. Anti-aging therapy is used to treat aging caused by uncorrected DNA damage or other cellular stresses.
In the forecast period (2018-2023), the global longevity and anti-aging market will grow rapidly due to increased attention to stem cell research and the growing demand for cell assays in research and development.
Click here to get this report with incredible discounts.
The growth of the elderly population worldwide and the growing awareness of anti-aging products among generation Y and subsequent generations are the main factors that are expected to contribute to the growth of the global market for longevity and anti-aging products. Factors such as the growing level of disposable income and progress in anti-aging technologies will also contribute to the growth of the global longevity and anti-aging market in the forecast period (2018-2023).
The growing elderly population around the world will create a huge potential for market growth.
Senolytics, placental stem cells and blood transfusion are among the most popular technologies gaining momentum in the market of longevity and anti–aging. Companies and startups around the world, such as Unity Biotechnology, Human Longevity Inc., Calico Life Sciences, Acorda Therapeutics, etc., are actively working in this field to increase human life expectancy, paying special attention to the study of genomics, microbiome, bioinformatics, stem cell treatment, etc. These factors will drive market growth during the forecast period.
The global durability and anti-aging market is projected to grow during the forecast period from 2018 to 2023.
The report provides an analysis based on each market segment, including treatment methods and applications. The therapy segment is further subdivided into senolytic drug therapy, gene therapy, immunotherapy and others. Senolytic drug therapy held the largest market share in 2017. The fastest growth of the gene therapy segment is due to large investments in genomics.
Portal "Eternal youth" http://vechnayamolodost.ru